Global Partners logo

Global Partners

GLP | NYSE
Chart Builder DCF Calculator
$43.52
-$0.78 (-1.76%)
At close: Nov 16, 2026, 4:00 PM ET
$43.52
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:01 PM ET
-1.76%

Rating

Updated: Nov 16, 2026
74.5
-0.8 pts
Fundamentals Excellent
Market Sentiment Neutral
Moat Narrow
Sector Rank #38/294 (Top 13%)

Key Statistics

Market Data

Market Cap $1.47B
1D Range
43.11 44.50
52W Range
39.58 54.07

Valuation (TTM)

PE 7.90
PB 2.12
EV/EBITDA 7.07

Valuation (NTM)

Forward PE 7.53
Forward PEG 0.05
Price Target $46.00
Loading financial charts...

Profile

Global Partners LP engages in the purchasing, selling, gathering, blending, storing, and logistics of transporting gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude ...

Sector Energy
Employees 4,700
IPO Date Oct 4, 2005
Fiscal Year January - December

Latest News

Omada Health Presents AI-Powered Meal Feedback Research and 12-Month GLP-1 Care Track Outcomes at ObesityWeek 2026

18 hours ago · globenewswire.com

Omada Health Presents AI-Powered Meal Feedback Research and 12-Month GLP-1 Care Track Outcomes at ObesityWeek 2026
CVS says GLP-1s save money when priced below $350 per month

1 day ago · nypost.com

CVS says GLP-1s save money when priced below $350 per month
Global Partners (GLP) Moves to Strong Buy: Rationale Behind the Upgrade

4 days ago · zacks.com

Global Partners (GLP) Moves to Strong Buy: Rationale Behind the Upgrade
Best Value Stocks to Buy for November 12th

4 days ago · zacks.com

Best Value Stocks to Buy for November 12th
Will Wegovy Pill Drive Renewed GLP-1 Growth Momentum for Novo Stock?

5 days ago · zacks.com

Will Wegovy Pill Drive Renewed GLP-1 Growth Momentum for Novo Stock?
Sales of Pharmaceuticals, GLP-1s Send McKesson Shares to New Highs

5 days ago · fxempire.com

Sales of Pharmaceuticals, GLP-1s Send McKesson Shares to New Highs
Hims & Hers Health: Don't Nitpick Quarterly Results

6 days ago · seekingalpha.com

Hims & Hers Health: Don't Nitpick Quarterly Results
Eli Lilly vs Novo Nordisk: What's the Better GLP-1 Stock to Buy?

6 days ago · fool.com

Eli Lilly vs Novo Nordisk: What's the Better GLP-1 Stock to Buy?
Conexeu Sciences Launches Human Collagen Initiative for Regenerative Aesthetics as GLP-1 Drives Demand for Tissue Restoration

6 days ago · globenewswire.com

Conexeu Sciences Launches Human Collagen Initiative for Regenerative Aesthetics as GLP-1 Drives Demand for Tissue Restoration
Biomea Fusion Announces Poster Presentation of Phase 1 Results for BMF-650, its Investigational Next-Generation Oral Small Molecule GLP-1 Receptor Agonist, at ObesityWeek® 2026

6 days ago · globenewswire.com

Biomea Fusion Announces Poster Presentation of Phase 1 Results for BMF-650, its Investigational Next-Generation Oral Small Molecule GLP-1 Receptor Agonist, at ObesityWeek® 2026

Earnings

Latest Earnings
Nov 6, 2026
EPS
$1.26
Miss -21.74%
REV
$6.68B
Miss -9.82%
Next Earnings
Feb 26, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Hold
Price Target
$46.00
Upside
+5.70%
Buy (0)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.